BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26232852)

  • 1. Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-Pair Analysis.
    Rades D; Huttenlocher S; Šegedin B; Perpar A; Conde AJ; Garcia R; Veninga T; Stalpers LJ; Cacicedo J; Rudat V; Schild SE
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):368-72. PubMed ID: 26232852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroups.
    Rades D; Conde-Moreno AJ; Cacicedo J; Veninga T; Segedin B; Stanic K; Rudat V; Schild SE
    Radiat Oncol; 2018 Feb; 13(1):21. PubMed ID: 29422106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.
    Rades D; Huttenlocher S; Veninga T; Bajrovic A; Bremer M; Rudat V; Schild SE
    Radiat Oncol; 2015 Apr; 10():90. PubMed ID: 25889036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients?
    Rades D; Dahm-Daphi J; Rudat V; Schulte R; Stalpers LJ; Veninga T; Hoskin PJ
    Strahlenther Onkol; 2006 Dec; 182(12):708-12. PubMed ID: 17149577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.
    Rades D; Veninga T; Stalpers LJ; Schulte R; Hoskin PJ; Poortmans P; Schild SE; Rudat V
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):182-8. PubMed ID: 16198069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.
    Rades D; Stalpers LJ; Veninga T; Schulte R; Hoskin PJ; Obralic N; Bajrovic A; Rudat V; Schwarz R; Hulshof MC; Poortmans P; Schild SE
    J Clin Oncol; 2005 May; 23(15):3366-75. PubMed ID: 15908648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.
    Rades D; Fehlauer F; Veninga T; Stalpers LJ; Basic H; Hoskin PJ; Rudat V; Karstens JH; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):532-7. PubMed ID: 17084539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.
    Rades D; Karstens JH; Hoskin PJ; Rudat V; Veninga T; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):525-31. PubMed ID: 17141977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a multicenter study investigating the potential impact of the overall treatment time on outcomes of radiation therapy alone with 5×4 Gy for metastatic epidural spinal cord compression.
    Rades D; Veninga T; Conde-Moreno AJ; Cacicedo J; Metz M; Šegedin B; Norkus D; Rudat V; Schild SE
    Pract Radiat Oncol; 2017; 7(2):137-144. PubMed ID: 28274397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor function and survival following radiotherapy alone for metastatic epidural spinal cord compression in melanoma patients.
    Huttenlocher S; Sehmisch L; Rudat V; Rades D
    J Dermatol; 2014 Dec; 41(12):1082-6. PubMed ID: 25327333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression.
    Rades D; Lange M; Veninga T; Rudat V; Bajrovic A; Stalpers LJ; Dunst J; Schild SE
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):228-34. PubMed ID: 18539406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.
    Rades D; Rudat V; Veninga T; Stalpers LJ; Hoskin PJ; Schild SE
    Cancer; 2008 Sep; 113(5):1090-6. PubMed ID: 18642349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.
    Rades D; Hoskin PJ; Stalpers LJ; Schulte R; Poortmans P; Veninga T; Dahm-Daphi J; Obralic N; Wildfang I; Bahrehmand R; Engenhart-Cabilic R; Schild SE
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1452-7. PubMed ID: 16413695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy of metastatic spinal cord compression in very elderly patients.
    Rades D; Hoskin PJ; Karstens JH; Rudat V; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):256-63. PubMed ID: 17189074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors.
    Rades D; Huttenlocher S; Bajrovic A; Karstens JH; Adamietz IA; Kazic N; Rudat V; Schild SE
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e861-8. PubMed ID: 21277114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of two different radiation schedules for metastatic spinal cord compression considering a new prognostic factor.
    Rades D; Karstens JH
    Strahlenther Onkol; 2002 Oct; 178(10):556-61. PubMed ID: 12386787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression.
    Rades D; Conde-Moreno AJ; Cacicedo J; Veninga T; Segedin B; Stanic K; Schild SE
    Radiat Oncol; 2018 Dec; 13(1):257. PubMed ID: 30594231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study.
    Rades D; Fehlauer F; Stalpers LJ; Wildfang I; Zschenker O; Schild SE; Schmoll HJ; Karstens JH; Alberti W
    Cancer; 2004 Dec; 101(11):2687-92. PubMed ID: 15493037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy With 4 Gy × 5 Versus 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01).
    Rades D; Šegedin B; Conde-Moreno AJ; Garcia R; Perpar A; Metz M; Badakhshi H; Schreiber A; Nitsche M; Hipp P; Schulze W; Adamietz IA; Norkus D; Rudat V; Cacicedo J; Schild SE
    J Clin Oncol; 2016 Feb; 34(6):597-602. PubMed ID: 26729431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC)].
    Rades D; Stalpers LJ; Veninga T; Schulte R; Hoskin PJ; Alberti W
    Strahlenther Onkol; 2005 Sep; 181(9):595-600. PubMed ID: 16170487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.